2 results
Not approvedWill not start
The primary objective of this study is to demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) is noninferior to Timolol Ophthalmic Solution (0.5% or 0.25%) in pediatric glaucoma patients.
Approved WMORecruiting
The primary objective is to assess the fixation and migration patterns of the CapFlex PIP implant system (KLS Martin Group) in vivo, using mRSA, over 10 years. Furthermore, the safety and usability of the tantalum markers and the marker inserter…